160 related articles for article (PubMed ID: 11126406)
1. Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes.
Steinbrenner H; Lohmann T; Ostendorf B; Scherbaum WA; Seissler J
Diabetologia; 2000 Nov; 43(11):1381-4. PubMed ID: 11126406
[TBL] [Abstract][Full Text] [Related]
2. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
3. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
Seissler J; Atik Y; Klinghammer A; Scherbaum WA
Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
[TBL] [Abstract][Full Text] [Related]
4. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
[TBL] [Abstract][Full Text] [Related]
9. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
Leslie RD; Atkinson MA; Notkins AL
Diabetologia; 1999 Jan; 42(1):3-14. PubMed ID: 10027571
[No Abstract] [Full Text] [Related]
10. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
[TBL] [Abstract][Full Text] [Related]
11. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
12. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA
Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308
[TBL] [Abstract][Full Text] [Related]
14. Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in Type I diabetic patients.
Roll U; Turck CW; Gitelman SE; Rosenthal SM; Nolte MS; Masharani U; Ziegler AG; Baekkeskov S
Diabetologia; 2000 May; 43(5):598-608. PubMed ID: 10855535
[TBL] [Abstract][Full Text] [Related]
15. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to SOX13 (ICA12) are associated with type 1 diabetes.
Kasimiotis H; Fida S; Rowley MJ; Mackay IR; Zimmet PZ; Gleason S; Rabin DU; Myers MA
Autoimmunity; 2001; 33(2):95-101. PubMed ID: 11264788
[TBL] [Abstract][Full Text] [Related]
17. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
18. Dual-parameter model for prediction of type I diabetes mellitus.
Eisenbarth GS; Gianani R; Yu L; Pietropaolo M; Verge CF; Chase HP; Redondo MJ; Colman P; Harrison L; Jackson R
Proc Assoc Am Physicians; 1998; 110(2):126-35. PubMed ID: 9542768
[TBL] [Abstract][Full Text] [Related]
19. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
20. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
